Prostaglandin D₂ (PGD₂)

Class Eicosanoid / lipid signal (arachidonic acid–derived)Receptor DP1/PTGDR

Function

Prostaglandin D2 is a lipid-derived signaling hormone involved in inflammatory communication, allergic responses, sleep regulation, vascular signaling, and immune-cell coordination. PGD2 participates in local tissue responses during inflammation and plays important roles within respiratory tissues, nervous tissue, skin, and immune environments. It contributes to regulation of vascular tone, bronchial responsiveness, leukocyte recruitment, and inflammatory mediator signaling.

Within the nervous system, PGD2 also participates in sleep-associated signaling pathways and circadian neurophysiology. In immune tissues, mast cells are major producers of PGD2 during allergic and inflammatory activation. Depending on receptor subtype activation and tissue context, PGD2 can either amplify inflammatory signaling or participate in regulatory feedback processes that influence immune balance and tissue adaptation.

Production

PGD2 is synthesized from arachidonic acid released from membrane phospholipids through phospholipase A2 activity. Cyclooxygenase enzymes convert arachidonic acid into prostaglandin H2 intermediates, which are then converted into PGD2 by prostaglandin D synthase enzymes.

Production occurs mainly in mast cells, macrophages, dendritic cells, brain tissue, respiratory epithelium, and additional inflammatory tissues. Unlike classical endocrine hormones stored in vesicles, PGD2 is synthesized rapidly on demand in response to cellular activation, immune signaling, or tissue stress. This allows localized and rapidly adjustable signaling responses.

Regulation

PGD2 synthesis is regulated by inflammatory cytokines, allergen exposure, oxidative stress, phospholipase signaling pathways, immune-cell activation, and cyclooxygenase enzyme activity. Mast-cell degranulation strongly increases local PGD2 production during allergic and inflammatory responses.

PGD2 acts through DP1 and DP2 receptor pathways that influence cyclic AMP signaling, calcium regulation, leukocyte migration, vascular tone, and smooth muscle responsiveness. Enzymatic degradation pathways rapidly limit signaling duration and help maintain local tissue specificity. Through these integrated lipid-signaling systems, PGD2 contributes to inflammatory adaptation, allergic physiology, neuroendocrine sleep signaling, immune-cell coordination, and vascular regulation.

Identity & Secretion

Primary Source GlandNo single gland; high production by mast cells; PTGDS in brain/choroid plexus; adipose tissue
Secretion PatternBasal COX-1 output; inducible COX-2/HPGDS surge with cytokines/allergen exposure
PrecursorArachidonic acid → COX-1/COX-2 → PGH₂ → PGD synthases (HPGDS/PTGDS) → PGD₂

Nutrient Requirements

Nutrient Precursors
  • Linoleic acid (18:2n-6) → arachidonic acid; alpha-linolenic acid (18:3n-3) → EPA (competes in eicosanoid pathways)
Required Vitamins
  • Niacin (B3) and Riboflavin (B2) for redox coenzymes; Vitamin C (antioxidant milieu)
Required Minerals
  • Iron (heme in COX), Magnesium (enzyme/cofactor), Selenium (redox enzymes)

Key Foods

  • ALA-rich plants (flaxseed, chia, walnuts) and polyphenol-rich fruits/vegetables/legumes/whole grains/herbs that modulate COX-2 expression (context only)

Targets & Signaling

Target Tissues
  • Immune cells, airway smooth muscle, vasculature, CNS, adipose, skin
Feedback Loops
  • Local autocrine/paracrine loops; PGD₂ can shape subsequent cytokine/chemokine signaling
Second Messengers
  • DP1: ↑cAMP/PKA; DP2: Gi/βγ → Ca²⁺ mobilization; context-dependent MAPK activation
Pathways Involved
  • PLA₂ release → COX-1/2 → PGH₂ → HPGDS/PTGDS → PGD₂; receptor signaling via DP1 (cAMP/PKA) and DP2 (Gi/Ca²⁺, chemotaxis)

Key Functions

  • Allergic and inflammatory signaling, vasodilation/vascular tone, bronchial tone, sleep/thermoregulation, adipose biology

Plant-Based Focus

  • Whole-food plant patterns emphasizing balanced n-6:n-3 intake (ALA) and diverse polyphenols may favor eicosanoid balance (context only)

Clinical Context

Assay Notes
Very labile oxylipin; strict preanalytical control required. LC-MS/MS of stabilized samples recommended; interpret by matrix and stimulus.

Linked Knowledge

Phytochemicals
  • Quercetin, resveratrol, curcumin, EGCG (reported COX-2/HPGDS pathway modulation in experimental models—informational only)
Foods
  • Flaxseed, chia, walnuts, oats, legumes, colorful fruits/vegetables, culinary herbs/spices
Vitamins
  • B2, B3, C (enzyme/redox milieu—context)
Minerals
  • Iron, Magnesium, Selenium
Cancers (context)
  • COX/PGD₂ axis studied in tumor microenvironments and immunity (contextual, informational only)
Ailments
  • Allergic airway inflammation and atopic contexts involve PGD₂–DP2 signaling (context only, non-diagnostic)

Dietary Modulators

  • Higher ALA/EPA intake and polyphenols may support balanced eicosanoid profiles (context only)

Inhibitors / Activators

Inhibitors
  • Excess n-6 substrate and inflammatory cytokines/allergens can increase PGD₂ generation (context only)
Activators
  • Allergen-driven mast cell activation; IL-4/IL-13 and other cytokines upregulate COX-2/HPGDS

Summary

Locally acting eicosanoid from arachidonic acid that shapes allergic inflammation, vascular/bronchial tone, sleep, and adipose biology via DP1/DP2 receptors.

SUMMARY OF EFFECTS ON THE BODY

Context-only: dietary ALA and polyphenols may modulate upstream enzymes toward balanced eicosanoid signaling.

Research

COX-1 (P23219), COX-2 (P35354); HPGDS (O60760); PTGDS (P41222). See Endotext/UniProt/PubChem for enzyme/receptor details.
Created: Nov 11, 2025 Updated: May 27, 2026